1. Arunlakshana, O. & Schild, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol Chemother.
14, 48–58.
2. Aultura, G.P. & Karim S.M.M. (1972). Effects of prostaglandins A1, A2, B1, B3, E2, and F2α on human umbilical cord vessels. Prostaglandins, 8, 411–416.
3. Burk, R.M., Gac, T.S., Krauss, A.H., Woodward, D.W. (1994). Synthesis of a novel series of 3-oxo-2,4-dioxo-bi-cyclo [3.2.1] octanes. Pharmacological evidence for two thromboxane receptor subtypes. In Abstracts for the 9th international conference on prostaglandins and related substances, p. 43. Fondazione Giovanni Lorenzini.
4. Clayton, J.K., Marshall, K., Sangha, R., Kennedy, F. & Senior, J. (1994). Comparison of uterine thromboxane receptors. In Abstracts for the 9th international conference on prostaglandins and related substances, p. 110. Fondazione Giovanni Lorenzini.
5. Coleman, R.A., Humphrey, P.P.A., Kennedy, I., Lumley, P. (1984). Prostanoid receptors-The development of a working classification. TIPS, 303-306